Table 4.
Analytical performances of the Lumipulse® G SARS-CoV-2 Ag on target populations in the detection of SARS-CoV-2 using a categorization of the risk system.
| Lumipulse® automated antigen detection | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Certain (>20.27 pg/mL) | Possible (1.32–20.27pg/mL) | Unlikely (≤1.32pg/mL) | |||||||||
| PCR result | N | Positive | Lowest CT | N | Negative | Positive | Lowest CT | N | Negative | Positive | Lowest CT |
| Overall | 279 | 14 | 3.89 | 46 | 39 | 7 | 15.7 | 219 | 214 | 5 | 22.61 |
| Scheduled hospitalizations | 93 | 1 | 12.73 | 6 | 4 | 2 | 15.7 | 86 | 85 | 1 | 26.04 |
| Contacts | 67 | 4 | 6.98 | 13 | 12 | 1 | 31.23 | 50 | 49 | 1 | 22.9 |
| Health workers | 119 | 9 | 3.89 | 27 | 23 | 4 | 19.92 | 83 | 80 | 3 | 22.61 |
| - With symptoms | 67 | 8 | 3.89 | 13 | 13 | - | - | 46 | 43 | 3 | 22.61 |